The C-reactive protein-triglyceride-glucose index and its obesity-derived indicators predict cardio-renal-metabolic multimorbidity: evidence from the UK biobank and CHARLS.
Aug 2026· Diabetes Research and Clinical Practice· Vol 240, pp.
113475
· 0 citations· 49 references
Medicine
TL;DR
CTI-derived obesity-related indices, especially CTI-WC and CTI-WHtR, were associated with CRMM incidence and progression and may improve risk stratification and may improve risk stratification beyond traditional measures.
Abstract
Background
Cardio-renal-metabolic multimorbidity is defined as the coexistence of cardiovascular disease, type 2 diabetes, and chronic kidney disease. We examined the relationships between C-reactive protein-triglyceride glucose-index and its five obesity derivatives with CRMM incidence and progression.
Methods
We included 374,513 participants from UK Biobank and 6,401 participants from CHARLS. Cox, RCS, and multistate models were used to assess incident CRMM and disease transitions. Predictive performance was evaluated using time-dependent ROC, C-index, NRI, and IDI.
Results
Over 15.98 years of follow-up, 13,315 participants developed CRMM.six indices were positively associated with CRMM risk in UK Biobank.CTI-WC showing the strongest association (HR 1.974, 95% CI 1.943-2.007), followed by CTI-WHtR (HR 1.919, 95% CI 1.890-1.950). Multistate analyses also supported associations with CRMM progression, particularly for transitions from healthy to FCRMD, again strongest for CTI-WC (HR 1.538, 95% CI 1.526-1.550). Adding CTI-derived indices improved prediction, with NRI ranging from 21.161% to 23.929%, IDI from 1.051% to 1.512%, and ΔC-index from 0.029 to 0.038 , suggesting improved risk stratification beyond traditional measures. In CHARLS, associations were directionally consistent but attenuated,likely due to the smaller validation cohort.
Conclusions
CTI-derived obesity-related indices, especially CTI-WC and CTI-WHtR, were associated with CRMM incidence and progression and may improve risk stratification.
The C-reactive protein-triglyceride-glucose index (CTI) is a comprehensive marker that reflects inflammation and insulin resistance. Cardiovascular-liver-metabolic (CLM) diseases caused by multiple factors may be related to insulin resistance, obesity, metabolism, etc. Our aim is to explore the association between the...
Background The C-reactive protein-triglyceride-glucose index (CTI) integrates inflammatory and metabolic markers, but recent studies have already linked CTI to stroke and cardiovascular outcomes. Whether CTI provides information beyond established risk factors in the U.S. general population remains uncertain. Methods W...
BACKGROUND
The associations and comparative discrimination of indices integrating inflammation, insulin resistance, and body shape within glycemic-status strata remain uncertain.
METHODS
We included 13,867 adults from the 1999-2010 and 2015-2018 National Health and Nutrition Examination Survey. Complex-survey weighte...
Junqi Liao, Jie Yang, Yuanjiang Zhao et al.· Diabetes Research and Clinic...· 0 citations
Among individuals with MASLD, CHG-related indices, particularly CHG-WHtR and CHG-WC, were associated with incident CMM and transition-specific disease progression and improved risk prediction, and readily available indices may help refine CMM risk stratification in MASLD.
K. Mu, Jing Zhang, Shuang Liang et al.· Cardiovascular Diabetology· 0 citations
Background The composite index of inflammation and insulin resistance (IR), the C-reactive protein (CRP)–triglyceride–glucose (TyG) index (CTI), has been suggested to be closely associated with cardiovascular disease. However, the relationship between the CTI and kidney injury (KI), including its subtypes [declined kid...
Meng-Meng Fan, Xue-Ping Zhang, Xian-Wei Tian et al.· Journal of Inflammation Rese...· 0 citations
The positive association between CTI-WHtR and mortality risk in the MASLD population was robust in both cohorts, but its independent discriminatory performance was generally weak, and its relative discriminatory performance varied across populations, lacking a stable cross-population advantage.
Guang-Jie Tu, Hang Zhai, Jun-Ming Xu et al.· BMC Cardiovascular Disorders· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.